Fluorescence in situ hybridization study of chromosome abnormalities of upper urinary tract urothelial carcinoma in paraffin-embedded tissue

American Journal of Clinical Pathology

Volumn 138, Issue 3, 2012, Pages 382-389

  Bing, Zhanyong ^a   Li, Jinhong ^b   Master, Stephen R ^a   Lee, Chyi Chia ^c   Puthiyaveettil, Raghunath ^a   Tomaszewski, John E ^d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aneuploidy; FISH; Upper urinary tract; Urothelial carcinoma

Indexed keywords

AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DIPLOIDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; PLOIDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84865416726     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPUXAP6P2GVBTI     Document Type: Article

References (25)

1. Batata M, Grabstald H. Upper urinary tract urothelial tumors. Urol Clin North Am. 1976;3:79-86.
2. Kirkali Z, Moffat LE, Deane RF, et al.Urothelial tumours of the upper urinary tract. Br J Urol. 1989;64:18-24. (Pubitemid 19177137)
3. Steffens J, Nagel R. Tumours of the renal pelvis and ureter: observations in 170 patients. Br J Urol. 1988;61:277-283.
4. Ikemoto K, Furuya T, Matsuda K, et al.Multicolor FISH and cytometric analyses allow classification of urothelial carcinomas into two subtypes, low- and high-grade tumors. Int J Oncol. 2004;25:893-898.
5. Bollmann M, Heller H, Bankfalvi A, et al.Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer? BJU Int. 2005;95:1219-1225. (Pubitemid 40799434)
6. Marin-Aguilera M, Mengual L, Ribal MJ, et al.Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet. 2007;173:131-135. (Pubitemid 46281350)
7. Marin-Aguilera M, Mengual L, Ribal MJ, et al.Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol. 2007;51:409-415; discussion 415.
8. Zellweger T, Benz G, Cathomas G, et al.Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer. 2006;119:1660-1665. (Pubitemid 44258773)
9. Akkad T, Brunner A, Pallwein L, et al.Fluorescence in situ hybridization for detecting upper urinary tract tumors- a preliminary report. Urology. 2007;70:753-757. (Pubitemid 350030237)
10. Fadl-Elmula I, Gorunova L, Mandahl N, et al.Cytogenetic analysis of upper urinary tract transitional cell carcinomas. Cancer Genet Cytogenet. 1999;115:123-127.
11. R Development Core Team. R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing; 2011.
12. Steidl C, Simon R, Burger H, et al.Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium. J Pathol. 2002;198:115-120. (Pubitemid 34966215)
13. Tsukamoto M, Matsuyama H, Oba K, et al.Numerical aberrations of chromosome 9 in bladder cancer: a possible prognostic marker for early tumor recurrence. Cancer Genet Cytogenet. 2002;134:41-45. (Pubitemid 34462108)
14. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, et al.Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol. 2010;28:401-408.
15. Roupret M, Azzouzi AR, Cussenot O. Microsatellite instability and transitional cell carcinoma of the upper urinary tract. BJU Int. 2005;96:489-492. (Pubitemid 41224314)
16. Roupret M, Yates DR, Comperat E, et al.Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 2008;54:1226-1236.
17. Sandberg AA, Berger CS. Review of chromosome studies in urological tumors: II, cytogenetics and molecular genetics of bladder cancer. J Urol. 1994;151:545-560. (Pubitemid 24054683)
18. Ried T, Heselmeyer-Haddad K, Blegen H, et al.Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer. 1999;25:195-204. (Pubitemid 29266688)
19. Stadler WM, Steinberg G, Yang X, et al.Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Clin Cancer Res. 2001;7:1676-1682. (Pubitemid 32708635)
20. Stewart GD, Bariol SV, Grigor KM, et al.A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int. 2005;95:791-793. (Pubitemid 40547208)
21. Oosterlinck W. Guidelines on diagnosis and treatment of superficial bladder cancer. Minerva Urol Nefrol. 2004;56:65-72. (Pubitemid 38937540)
22. Chow NH, Tzai TS, Cheng HL, et al.Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test? Urol Int. 1994;53:18-23.
23. Lodde M, Mian C, Wiener H, et al.Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report. Urology. 2001;58:362-366. (Pubitemid 32816351)
24. Potts SA, Thomas PA, Cohen MB, et al.Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract. Mod Pathol. 1997;10:657-662. (Pubitemid 27321755)
25. Laudadio J, Keane TE, Reeves HM, et al.Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005;96:1280-1285. (Pubitemid 41743924)